Nanjing Gaoke Crescita futura

Future criteri di controllo 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Nanjing Gaoke.

Informazioni chiave

n/a

Tasso di crescita degli utili

n/a

Tasso di crescita dell'EPS

Real Estate crescita degli utili	40.2%
Tasso di crescita dei ricavi	n/a
Rendimento futuro del capitale proprio	n/a
Copertura analitica	None
Ultimo aggiornamento	n/a

Aggiornamenti recenti sulla crescita futura

Recent updates

Earnings Troubles May Signal Larger Issues for Nanjing Gaoke (SHSE:600064) Shareholders

Nov 03

Improved Earnings Required Before Nanjing Gaoke Company Limited (SHSE:600064) Stock's 25% Jump Looks Justified

Oct 01

Is Nanjing Gaoke (SHSE:600064) Using Debt In A Risky Way?

Aug 27

Earnings Working Against Nanjing Gaoke Company Limited's (SHSE:600064) Share Price

Aug 01

We Think You Can Look Beyond Nanjing Gaoke's (SHSE:600064) Lackluster Earnings

May 03

Benign Growth For Nanjing Gaoke Company Limited (SHSE:600064) Underpins Its Share Price

Apr 18

In questa sezione di solito presentiamo le proiezioni di crescita dei ricavi e degli utili basate sulle stime di consenso degli analisti professionisti per aiutare gli investitori a capire la capacità della società di generare profitti. Tuttavia, poiché Nanjing Gaoke non ha fornito dati sufficienti sul passato e non ha previsioni degli analisti, i suoi utili futuri non possono essere calcolati in modo affidabile estrapolando i dati passati o utilizzando le previsioni degli analisti.

Si tratta di una situazione piuttosto rara, dato che il 97% delle società coperte da SimplyWall St dispone di dati finanziari passati.

Previsioni di crescita degli utili e dei ricavi

SHSE:600064 - Stime future degli analisti e dati finanziari passati (CNY Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
9/30/2024	2,011	1,728	-1,385	-1,361	N/A
6/30/2024	3,004	1,425	-2,497	-2,474	N/A
3/31/2024	3,808	1,445	-2,205	-2,181	N/A
12/31/2023	4,733	1,560	-2,198	-2,177	N/A
9/30/2023	6,772	2,182	-2,303	-2,289	N/A
6/30/2023	5,775	2,155	-2,173	-2,162	N/A
3/31/2023	5,262	2,375	-2,396	-2,392	N/A
12/31/2022	4,490	2,402	-1,874	-1,869	N/A
9/30/2022	2,691	2,286	-366	-359	N/A
6/30/2022	2,800	2,324	988	996	N/A
3/31/2022	3,405	2,467	1,138	1,147	N/A
12/31/2021	4,935	2,352	491	501	N/A
9/30/2021	4,706	2,160	-322	-312	N/A
6/30/2021	4,413	2,025	-1,561	-1,552	N/A
3/31/2021	4,140	1,979	-2,728	-2,720	N/A
12/31/2020	2,924	2,016	-2,184	-2,178	N/A
9/30/2020	4,119	2,190	-2,130	-2,125	N/A
6/30/2020	4,272	2,070	-638	-634	N/A
3/31/2020	3,357	1,529	774	778	N/A
12/31/2019	2,930	1,842	1,173	1,175	N/A
9/30/2019	2,053	1,626	2,269	2,286	N/A
6/30/2019	2,262	1,450	1,677	1,697	N/A
3/31/2019	2,890	1,676	1,038	1,057	N/A
12/31/2018	3,425	958	442	465	N/A
9/30/2018	4,321	1,201	-470	-448	N/A
6/30/2018	4,131	1,136	N/A	-268	N/A
3/31/2018	3,759	1,029	N/A	667	N/A
12/31/2017	3,626	946	N/A	184	N/A
9/30/2017	2,365	562	N/A	105	N/A
6/30/2017	2,630	676	N/A	1,124	N/A
3/31/2017	3,874	759	N/A	1,493	N/A
12/31/2016	5,221	927	N/A	2,108	N/A
9/30/2016	6,234	1,033	N/A	2,490	N/A
6/30/2016	6,340	1,094	N/A	1,680	N/A
3/31/2016	5,151	761	N/A	1,295	N/A
12/31/2015	3,882	848	N/A	1,719	N/A
9/30/2015	3,764	1,036	N/A	1,705	N/A
6/30/2015	3,293	862	N/A	1,747	N/A
3/31/2015	3,025	902	N/A	1,421	N/A
12/31/2014	3,286	610	N/A	1,268	N/A
9/30/2014	3,014	438	N/A	1,007	N/A
6/30/2014	3,279	456	N/A	704	N/A
3/31/2014	3,880	434	N/A	713	N/A
12/31/2013	3,529	430	N/A	910	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Insufficient data to determine if 600064's forecast earnings growth is above the savings rate (2.9%).

Guadagni vs Mercato: Insufficient data to determine if 600064's earnings are forecast to grow faster than the CN market

Guadagni ad alta crescita: Insufficient data to determine if 600064's earnings are expected to grow significantly over the next 3 years.

Ricavi vs Mercato: Insufficient data to determine if 600064's revenue is forecast to grow faster than the CN market.

Ricavi ad alta crescita: Insufficient data to determine if 600064's revenue is forecast to grow faster than 20% per year.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Insufficient data to determine if 600064's Return on Equity is forecast to be high in 3 years time

Nanjing Gaoke Crescita futura

Future criteri di controllo 0/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Price target decreased to CN¥9.54

Price target decreased to CN¥9.54

Analysts increase EPS estimates to CN¥1.44

Price target raised to CN¥12.82

Recent updates

Earnings Troubles May Signal Larger Issues for Nanjing Gaoke (SHSE:600064) Shareholders

Third quarter 2024 earnings released: EPS: CN¥0.47 (vs CN¥0.30 in 3Q 2023)

Improved Earnings Required Before Nanjing Gaoke Company Limited (SHSE:600064) Stock's 25% Jump Looks Justified

Nanjing Gaoke Company Limited to Report Q3, 2024 Results on Oct 30, 2024

Investor sentiment improves as stock rises 15%

Second quarter 2024 earnings released: EPS: CN¥0.29 (vs CN¥0.30 in 2Q 2023)

Is Nanjing Gaoke (SHSE:600064) Using Debt In A Risky Way?

Earnings Working Against Nanjing Gaoke Company Limited's (SHSE:600064) Share Price

Dividend of CN¥0.28 announced

Nanjing Gaoke Company Limited to Report First Half, 2024 Results on Aug 30, 2024

We Think You Can Look Beyond Nanjing Gaoke's (SHSE:600064) Lackluster Earnings

Nanjing Gaoke Company Limited, Annual General Meeting, May 23, 2024

Full year 2023 earnings released: EPS: CN¥0.90 (vs CN¥1.39 in FY 2022)

Nanjing Gaoke Company Limited, Annual General Meeting, May 23, 2024

Benign Growth For Nanjing Gaoke Company Limited (SHSE:600064) Underpins Its Share Price

Nanjing Gaoke Company Limited to Report Q1, 2024 Results on Apr 27, 2024

Now 22% overvalued

Nanjing Gaoke Company Limited to Report Fiscal Year 2023 Results on Apr 27, 2024

Third quarter 2023 earnings released: EPS: CN¥0.30 (vs CN¥0.28 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.30 (vs CN¥0.43 in 2Q 2022)

First quarter 2023 earnings released: EPS: CN¥0.37 (vs CN¥0.39 in 1Q 2022)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.28 (vs CN¥0.30 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.43 (vs CN¥0.51 in 2Q 2021)

Price target decreased to CN¥9.54

Less than half of directors are independent

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Price target decreased to CN¥9.54

Third quarter 2021 earnings released: EPS CN¥0.42 (vs CN¥0.31 in 3Q 2020)

njing Hanxin Pharmaceutical Technology Co., Ltd. intends to acquire 51% stake in Nanjing Cuccess Pharmaceutical Co., Ltd. from Nanjing Gaoke Company Limited (SHSE:600064) for approximately CNY 180 million.

Second quarter 2021 earnings released: EPS CN¥0.71 (vs CN¥0.68 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.45 (vs CN¥0.48 in 1Q 2020)

New 90-day low: CN¥9.86

Third quarter earnings released

New 90-day low: CN¥10.13

First half earnings released

New 90-day high - CN¥12.06

Analysts increase EPS estimates to CN¥1.44

Price target raised to CN¥12.82

Nanjing Gaoke Company Limited to Report First Half, 2020 Results on Aug 31, 2020

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita